CFTR Modulator Treatment and Sweat Chloride in Cystic Fibrosis Patients

Active, Not Recruiting NCT03350828

Study Description

This study will collect sweat chloride values from 5000 Cystic Fibrosis (CF) patients using CFTR modulator therapies. Eligible subjects taking a CFTR modulator for at least 3 months will provide sweat samples for analysis. Clinical data will be collected from the Cystic Fibrosis Foundation Patient Registry. Patients who switch to a new modulator will be re-enrolled for a new sweat chloride value.

Study Details

Registry ID:
NCT03350828
Conditions:
Cystic Fibrosis
Phase:
Target Enrollment:
5,000 participants
Start Date:
Age Range:
0.333333–999 years
Healthy Volunteers:
No

Study Locations (56 sites)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →